1. Introduction {#sec1-ijms-20-00314}
===============

Seminal ejaculate is composed of secretions from testis (5%) and other accessory sex glands, such as seminal vesicles (50--65%), prostate (20--30%), and bulbourethral glands (\<5%) \[[@B1-ijms-20-00314],[@B2-ijms-20-00314]\]. The main cellular portion of the semen is composed by spermatozoa. However, semen also contains non-sperm cells known as round cells, either of spermatogenic or non-spermatogenic origin \[[@B3-ijms-20-00314]\]. Spermatogenic round cells include immature germ cells and degenerated spermatids, whereas non-spermatogenic round cells include exfoliating epithelial cells form prostate and seminal vesicles and inflammatory cells, such as leukocytes, lymphocytes, and macrophages \[[@B4-ijms-20-00314],[@B5-ijms-20-00314]\]. Basic semen analysis is performed on neat semen samples and includes the estimation of round cell concentrations. When round cells are present in excessive amounts (≥1 × 10^6^/mL), the Endtz test or peroxidase staining test is used to detect the leukocyte population \[[@B6-ijms-20-00314],[@B7-ijms-20-00314]\].

The presence of leukocytes ≥ 1 × 10^6^/mL is an indication of genital tract infection or inflammation \[[@B8-ijms-20-00314]\]. The level of seminal leukocytes are elevated in recurrent cigarette smoking and alcohol consuming men \[[@B9-ijms-20-00314],[@B10-ijms-20-00314]\]. These seminal leukocytes are high producers of reactive oxygen species (ROS), which are harmful for spermatozoa when present in excessive amounts, as they induce oxidative stress. ROS can cause nuclear and mitochondrial DNA damages, thus significantly affect sperm function and motility \[[@B11-ijms-20-00314]\]. To minimize the ROS levels, semen samples can be subjected to density gradient centrifugation to remove the seminal leukocytes \[[@B12-ijms-20-00314],[@B13-ijms-20-00314],[@B14-ijms-20-00314]\].

In the era of omics, sperm proteins constitute a great source for understanding the molecular mechanisms of sperm function. Mass spectrometry is a commonly used technique for quantitative proteomic studies \[[@B15-ijms-20-00314]\]. It provides the basis for understanding the biological pathways regulating the normal physiological function of spermatozoa. Sperm proteomic analysis starts with the isolation and separation of sperm cells from seminal plasma. For proteomic experiments, semen samples are frequently stored at −80 °C. However, while freezing the neat semen samples, spermatozoa are stored along with round cells and debris. When the frozen samples are thawed, the round cells present in semen burst. Hence, the extracted total protein will contain a mixture of both sperm and round cell proteins \[[@B16-ijms-20-00314]\]. Gradient centrifugation techniques are widely used to process the semen samples to obtain a pure population of spermatozoa. To date, some studies have used only pure cultures of sperm (without round cells) for global proteomic analysis \[[@B17-ijms-20-00314],[@B18-ijms-20-00314],[@B19-ijms-20-00314],[@B20-ijms-20-00314],[@B21-ijms-20-00314]\], whereas others have used neat semen samples \[[@B20-ijms-20-00314],[@B22-ijms-20-00314],[@B23-ijms-20-00314],[@B24-ijms-20-00314]\]. Thus, it is still unclear (1) whether the processing of semen samples have any interference in the sperm protein expression, and (2) what the contribution is of non-spermatogenic proteins in the evaluation of sperm proteomic profile. The objective of this study was to evaluate the impact of purification (by density gradient) on the sperm proteome detected by liquid chromatography-tandem mass spectrometry (LC-MS/MS) technique.

2. Results {#sec2-ijms-20-00314}
==========

2.1. Semen Parameters {#sec2dot1-ijms-20-00314}
---------------------

Sperm concentration (81.88 ± 45.51 × 10^6^/mL) and motility (69.79 ± 10.02%) were within normal reference ranges defined by the 2010 WHO guidelines \[[@B25-ijms-20-00314]\]. In the samples used for proteomic analysis, the average leukocyte concentration in leukocytospermic samples (*n* = 5) was 1.30 ± 0.57 × 10^6^/mL, while the average round cell concentration for samples (*n* = 5) with round cells \< 1 × 10^6^/mL was 0.50 ± 0.26 × 10^6^/mL ( [Supplementary Table S1](#app1-ijms-20-00314){ref-type="app"}).

2.2. Proteomic Profile of Spermatozoa in Different Groups {#sec2dot2-ijms-20-00314}
---------------------------------------------------------

LC-MS/MS analysis of pooled samples from group 1, 2, 3, and 4 resulted in a total of 1638, 1393, 1755, and 1404 proteins, respectively. A total of 1486 proteins were identified in control group (leukocyte pure culture). Variation in the total number of proteins identified for triplicate runs were 2.01%, 4.01%, 1.74%, and 9.37% in group 1, 2, 3, and 4, respectively ([Figure 1](#ijms-20-00314-f001){ref-type="fig"}a,b, [Supplementary Table S2](#app1-ijms-20-00314){ref-type="app"}). Comparative analysis of sperm proteins in group 1 vs. 3 (neat semen) revealed a total of 26 (1.18%) DEPs. Among them, 16 DEPs were overexpressed and 10 DEPs were underexpressed in group 3 ([Figure 1](#ijms-20-00314-f001){ref-type="fig"}a). When comparing group 2 vs. 4 (65% gradient processed semen), only six (0.31%) DEPs were identified ([Figure 1](#ijms-20-00314-f001){ref-type="fig"}b). In group 4, four proteins were underexpressed (AKAP3: A-kinase anchor protein 3, CLPTM1: cleft lip and palate transmembrane protein 1, SLC25A15: mitochondrial ornithine transporter 1, and FAM210A: protein FAM210A), the mitochondrial protein cytochrome c oxidase subunit 6A1 was overexpressed, and monocarboxylate transporter 10 (SLC16A10) was uniquely expressed in group 2. The DEPs differed in their abundance in all the four different groups ([Table 1](#ijms-20-00314-t001){ref-type="table"} and [Table 2](#ijms-20-00314-t002){ref-type="table"}). Lists of all the proteins detected in group 1, 2, 3, and 4 and control group are provided in [Supplementary Table S3](#app1-ijms-20-00314){ref-type="app"}.

2.3. Comparative Analysis of Human Sperm Protein and Leukocyte Protein {#sec2dot3-ijms-20-00314}
----------------------------------------------------------------------

Proteomic profile of group 1, group 3, and control group revealed only 11 DEPs were identified in all three groups. Key proteins associated with sperm function (IZUMO1, PSMD3) were absent and ATP1A1 was underexpressed in control group ([Table 3](#ijms-20-00314-t003){ref-type="table"}).

2.4. Molecular Pathways Regulated by DEPs in Spermatozoa {#sec2dot4-ijms-20-00314}
--------------------------------------------------------

Networks generated for DEPs between group 1 and 3 using IPA software revealed that 15 proteins were involved in the cell death and survival, cellular compromise, cellular function, and maintenance pathways ([Figure 2](#ijms-20-00314-f002){ref-type="fig"}a). Whereas aberrant expression of 10 proteins was associated with processes such as cellular assembly and organization, cell signaling, and molecular transport in the spermatozoa ([Figure 2](#ijms-20-00314-f002){ref-type="fig"}b). Functional network analysis also identified Izumo sperm-egg fusion protein 1 (IZUMO1) as a key molecule regulating the cellular assembly and organization, embryonic development, and organismal development pathways ([Figure 2](#ijms-20-00314-f002){ref-type="fig"}c).

3. Discussion {#sec3-ijms-20-00314}
=============

Cellular and molecular functions of a cell are regulated by proteins. In proteomics, selection of a suitable sample, protein extraction technique, and contaminant removal methods are very critical. Transcriptionally and translationally silent spermatozoa depend on the proteins and their post-translational modifications in order to carry out their normal physiological functions to ultimately fertilize the oocyte \[[@B26-ijms-20-00314],[@B27-ijms-20-00314]\]. Therefore, accurate identification and quantification of proteins in mature and immature spermatozoa provides insight into the function of each protein. Concentration of proteins varies from sample to sample, depending on the yield of the spermatozoa and other cells co-existing with sperm cells. In semen, spermatozoa are present along with other non-sperm cells, especially round cells of spermatogenic and non-spermatogenic origin \[[@B3-ijms-20-00314],[@B4-ijms-20-00314],[@B5-ijms-20-00314]\]. In general, prior to the use of semen samples in proteomic experiments, they are stored as whole ejaculate at −80 °C. However, it remains to be elucidated what the contribution is of the non-spermatogenic proteins to the evaluation of sperm proteome.

In this study, the intra-assay variation for group 2 and 4 was 4.01% and 9.37%, respectively ([Figure 2](#ijms-20-00314-f002){ref-type="fig"}b). We have identified that only six proteins were differentially expressed between group 2 and 4 ([Table 1](#ijms-20-00314-t001){ref-type="table"}). This indicates that the number of DEPs identified is very negligible (0.31%) compared with the total number of proteins identified in each group individually ([Figure 2](#ijms-20-00314-f002){ref-type="fig"}b). The majority of the proteins (AKAP3, CLPTM1, SLC25A15, and FAM210A) were underexpressed in group 4, while proteins SLC16A10 and COX6A1 were overexpressed ([Table 1](#ijms-20-00314-t001){ref-type="table"}).

Functional annotation of the identified DEPs revealed that the proteins AKAP3 and COX6A1 are associated with sperm function. AKAP3 tyrosine phosphorylation levels regulates the degradation of AKAP3, which in turn is essential for the sperm capacitation process \[[@B28-ijms-20-00314]\]. It is exclusively present in the principal piece of the flagellum of mature spermatozoa and is also expressed in elongated spermatids \[[@B29-ijms-20-00314]\]. In the present study, AKAP3 was underexpressed in group 4 compared to group 2, suggesting the predominant existence of immature spermatozoa in semen samples with round cells and leukocytes \> 1 × 10^6^/mL. Mitochondrial protein COX6A1 plays a protective role during the excessive production of ROS \[[@B30-ijms-20-00314]\]. Downregulation of COX6A1 in group 2 shows the presence of abnormal spermatozoa (with mitochondrial dysfunction) compared to group 4. Overall, the difference in the expression of proteins associated with sperm function, along with other proteins, are mainly due to the presence of abnormal spermatozoa in leukocytospermic samples. Therefore, despite the use of density gradient centrifugation to separate sperm population from non-sperm cells, the protein profile of normal spermatozoa from two different methods does not match exactly. This is mainly because of the presence of spermatozoa with varying maturation levels in the semen \[[@B31-ijms-20-00314]\].

We also compared the sperm protein profile of frozen neat semen samples containing round cells and leukocytes ≥ 1 × 10^6^/mL (group 1) with samples having round cells \< 1 × 10^6^/mL (group 3). A total of 26 proteins (1.18%) were differentially expressed between group 1 and 3 ([Figure 2](#ijms-20-00314-f002){ref-type="fig"}a). These DEPs were less than the intra-assay variability observed in group 1 (2.01%) and group 3 (1.74%). Bioinformatic analysis identified the top networks in which these DEPs were involved in cellular functions, such as (i) cell death and survival, cellular compromise, cellular function, and maintenance, and (ii) cellular assembly and organization, cell signaling, and molecular transport.

From the top networks, we noticed the overexpression of sperm specific proteins, such as ARSA, ALDH1A1, lactotransferrin (LTF), and calreticulin (CALR). ALDH1A1 is an indicator for impaired spermatogenesis or generation of abnormal sperm cells \[[@B32-ijms-20-00314]\]. Overexpression of ALDH1 in group 1 suggest the higher abundance of spermatogenic round cells. Similarly, CALR protein is involved in the spermatogenic process and fertility potential \[[@B33-ijms-20-00314]\]. Our proteomic analysis data show an overexpression of these proteins, which indicate the higher presence of abnormal spermatogenic round cells in group 1 relative to group 3. The protein ARSA is involved in fertilization and interacts with the heat shock 70 KDa protein 2 (HSPA2) and sperm adhesion molecule 1 (SPAM1), mediating sperm-egg interaction \[[@B34-ijms-20-00314]\]. ARSA is also localized in acrosomal region of round and elongated spermatids \[[@B35-ijms-20-00314]\]. In our study, the overexpression of ARSA in group 1 suggests higher presence of round spermatids and immature spermatozoa compared to group 3. Moreover, the protein LTF, localized with the eppin protein complex on the surface of spermatozoa \[[@B36-ijms-20-00314]\], was overexpressed in group 1 ([Table 2](#ijms-20-00314-t002){ref-type="table"}). It is abundantly expressed in seminal plasma samples with increased ROS levels \[[@B37-ijms-20-00314]\]. Our LC-MS/MS results are in agreement with earlier reports suggesting that LTF is a sperm-specific protein. The identified networks suggest that these DEPs play an important role in spermatogenesis and maturation of spermatozoa, and alterations in their expression may compromise those mechanisms. This is substantiated by the presence of excessive round cells, including leukocytes in group 1, when compared with group 3. Expression of these proteins are either absent or very low in the control group (pure leukocyte culture) ([Table 3](#ijms-20-00314-t003){ref-type="table"}). Thus, non-spermatogenic protein contribution to the whole sperm proteome is not significant.

Network analysis also revealed IZUMO1 as a focus molecule ([Figure 2](#ijms-20-00314-f002){ref-type="fig"}c), which was overexpressed in group 3. IZUMO1 is a membrane protein highly specific to spermatozoa and essential for spermatozoa fusion with the oocyte \[[@B38-ijms-20-00314],[@B39-ijms-20-00314]\]. Likewise, isoform 4 of sodium/potassium-transporting ATPase subunit alpha-1 (ATP1A1) was also overexpressed in group 3 and it is essential for sperm capacitation \[[@B40-ijms-20-00314],[@B41-ijms-20-00314]\]. Another overexpressed protein was the 26S proteasome non-ATPase regulatory subunit 3 (PSMD3), a component of ubiquitin-proteasome pathway, which along with proteasome machinery, regulates the exocytosis of the acrosome during fertilization \[[@B42-ijms-20-00314],[@B43-ijms-20-00314]\]. The overexpression of IZUMO1, ATP1A1, and PSMD3 represents a sign of highly functional spermatozoa in group 3 relative to group 1. Therefore, the differential expression of proteins associated with sperm function between these groups is mainly due to the presence of abnormal sperm population in group 1 compared to group 3. Absence of IZUMO1 and PSMD3 proteins in leukocytes pure culture and significant expression of ATP1A1 in sperm samples ([Table 3](#ijms-20-00314-t003){ref-type="table"}) indicates that the interference of non-spermatogenic proteins with sperm proteome is very negligible.

Apart from the DEPs associated with sperm function, the remaining DEPs observed in group 1 when compared with group 3 were either absent or significantly expressed in spermatozoa ([Table 3](#ijms-20-00314-t003){ref-type="table"}). The functional pathways in which they are involved are of testicular or germ cell origin, and are not due to contamination of leukocytes or somatic cells. Therefore, the question of proteome contamination from other somatic round cells, including leukocytes, present in the semen is ruled out. Henceforth, the proteome of the samples containing round cells is rich in sperm proteins and proteins of non-spermatogenic origin were masked by sperm proteins. Thus, the purification of spermatozoa by density gradient is not essential for the accurate proteomic and bioinformatic analysis of sperm proteins.

This is the first study in the field of sperm proteomics that demonstrates the lack of interference of non-spermatogenic proteins in frozen semen samples. We validate the use of neat semen samples for sperm proteomic studies by LC-MS/MS. Further studies should examine the role of proteins in the immature germ cells (including spermatogenic round cells), aside from the known functions of proteins in mature and healthy sperm.

4. Materials and Methods {#sec4-ijms-20-00314}
========================

4.1. Semen Analysis {#sec4dot1-ijms-20-00314}
-------------------

This study was approved by the Institutional Review Board of Cleveland Clinic (Cleveland, OH, USA). A total of 14 donors (normozoospermic; *n* = 14) enrolled in the study were provided with written consent. Semen samples were collected in a sterile container after a minimum of 48 h sexual abstinence. The samples were liquefied in an incubator at 37 °C for 30 mins. After complete liquefaction, macroscopic semen parameters, such as volume, color, pH, and viscosity, were measured. Viscosity of hyperviscous samples was broken down mechanically by repeated pipetting. The use of proteolytic enzymes was avoided for viscosity treatment as it interferes in proteomic analysis \[[@B44-ijms-20-00314]\]. Microscopic semen parameters including sperm concentration, motility, and presence of round cells were determined according to World Health Organization (WHO) guidelines \[[@B25-ijms-20-00314]\]. Additionally, Endtz test was conducted to measure leukocyte concentration (peroxidase positive cells) in semen samples when round cells ≥ 1 × 10^6^/mL \[[@B7-ijms-20-00314]\]. The semen specimens were first divided into (1) samples with round cells ≥1 × 10^6^/mL and leukocytes ≥1 × 10^6^/mL, and (2) samples with round cells \< 1 × 10^6^/mL.

4.2. Inclusion and Exclusion Criteria {#sec4dot2-ijms-20-00314}
-------------------------------------

Fertility status of the volunteers was not considered for including study subjects. Semen samples with more than 1.5 mL in volume were included, while samples with agglutination were excluded from the study.

4.3. Processing of Semen Samples {#sec4dot3-ijms-20-00314}
--------------------------------

Each sample was divided into two equal aliquots. One of the aliquots was immediately stored as unprocessed (neat semen) at −80 °C. The other aliquot was processed by 65% single gradient centrifugation ([Figure 3](#ijms-20-00314-f003){ref-type="fig"}). Briefly, the liquefied neat semen was overlaid on the 65% gradient solution and centrifuged at 300× *g* for 20 min. The seminal plasma was removed and discarded. The white buffy coat ring (containing round cells, including leukocytes, and debris) formed between the seminal plasma and the gradient was also discarded. Furthermore, the gradient containing spermatozoa was diluted in phosphate buffered saline (PBS) and centrifuged at 3000× *g* for 15 min. The sperm pellet free from any round cells was stored at −80 °C.

4.4. Experimental Groups {#sec4dot4-ijms-20-00314}
------------------------

Based on the concentration of round cells and leukocytes, and the sample processing, the experimental groups were defined as follows: Group 1 contained neat semen with round cells and leukocytes ≥ 1 × 10^6^/mL; group 2 contained neat semen with round cells ≥ 1 × 10^6^/mL that was processed by 65% density gradient (PureCeption, CooperSurgical Fertility and Genomic Solutions, Copenhagen, Denmark) to remove the round cells and leukocytes; group 3 contained neat semen with round cells \< 1 × 10^6^/mL; group 4 contained neat semen with round cells \< 1 × 10^6^/mL that was processed by 65% density gradient to remove the round cells. We have also included a human leukocyte pure culture (Innovative Research, Novi, MI, USA) as control group.

4.5. Preparation of Samples for Proteomic Analysis {#sec4dot5-ijms-20-00314}
--------------------------------------------------

Frozen samples were thawed at 37 °C and centrifuged at 3000× *g* for 10 min. Sperm pellet was resuspended and washed twice with PBS. The radio-immunoprecipitation assay (RIPA) lysis buffer (Sigma-Aldrich, St. Louis, MO, USA) supplemented with the proteinase inhibitor cocktail (Roche, Indianapolis, IN, USA) was added to the sperm pellet (approximately 100 µL/100 × 10^6^ spermatozoa). Samples were incubated overnight at 4 °C for a complete cell lysis. Then, samples were centrifuged at 13000× *g* for 20 min, the supernatant was aspirated to a new vial, and protein concentration was determined using the bicinchoninic acid (BCA) kit (Thermo, Rockford, IL, USA), according to the manufacturer's instructions. The same protocol was adapted for extraction of proteins from the leukocyte pellet.

4.6. Quantitative Proteomic Analysis {#sec4dot6-ijms-20-00314}
------------------------------------

Five sperm samples from each experimental group (1, 2, 3, and 4) were subjected to proteomic analysis by LC-MS/MS for maintaining biological variability. The same amount of protein was used from each individual sample to normalize the total protein concentration in each group. Sperm samples (*n* = 5) were pooled to create each treatment. Pooling of samples for sperm proteomic analysis is a common practice and is reported in previous reports \[[@B22-ijms-20-00314],[@B37-ijms-20-00314],[@B45-ijms-20-00314],[@B46-ijms-20-00314],[@B47-ijms-20-00314],[@B48-ijms-20-00314]\]. All the protein samples (\~30 µg/sample) were run in triplicate (N1, N2, and N3) in 1D-PAGE to maintain technical variability. After completion of electrophoresis, each gel lane was cut into 6 pieces. The samples (cut pieces) were alkylated with iodoacetamine and reduced with dithiothreitol. In-gel digestion was carried out using 5 μL trypsin (10 ng/μL) and 50 mM ammonium bicarbonate, and incubated overnight at room temperature. Peptides from the digested gel were extracted using acetonitrile (50%) with formic acid (5%). Finally, samples were diluted with 1% acetic acid and used for LC-MS/MS analysis.

4.7. Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Analysis {#sec4dot7-ijms-20-00314}
-----------------------------------------------------------------------

Firstly, samples (5 μL) of the peptide solutions were injected into high performance liquid chromatography (Dionex 15 cm × 75 μm, id Acclaim Pepmap C18, 2 μm, 100 Å reversed phase capillary chromatography) column. Fractions containing the peptides were eluted in acetonitrile/0.1% formic acid at a flow rate of 0.25 μL/min. Each peptide fraction was introduced into the source of Finnigan LTQ-Orbitrap Elite hybrid mass spectrometer on-line. The micro electrospray ion source was operated at 2.5 kV. Data dependent multitask ability of the instrument was used to complete a full spectral scan and to determine molecular weight and amino acid sequence of the peptides \[[@B37-ijms-20-00314]\].

4.8. Database Searching {#sec4dot8-ijms-20-00314}
-----------------------

Proteome Discoverer version 1.4.1.288 was used to extract tandem mass spectra. Mascot (Matrix Science, London, UK; version 2.3.02), Sequest (XCorr Only) (Thermo Fisher Scientific, San Jose, CA, USA; version IseNode in Proteome Discoverer 2.2.0.388) and X! Tandem (The Global Proteome Machine (GPM), thegpm.org; version CYCLONE (2010.12.01.1)) were used in data searching process for all the samples. Mascot and X! Tandem were set up to search the human SwissProtKB database (July 2017 version, 42210 entries), assuming the digestion enzyme trypsin. Sequest (XCorr Only) was set up to search Human_SwissProt_July2017.fasta (42152 entries), also assuming trypsin. Carbamidomethyl of cysteine was specified as a fixed modification and oxidation of methionine was specified as a variable modification. Additional settings for data searches include fragment ion mass tolerance of 0.60 Da and a parent ion tolerance of 10.0 PPM. Results of a Mascot search were filtered using a threshold peptide ion score of 40 and at least two matching peptides. For the Sequest searches, the results were filtered based on the XCorr scores \< 1.5 (+1 ions), \> 2.0 (+2 ions), \>2.5 (+3 ions). The false discovery rate (FDR) for these searches was determined to be less than 1%.

4.9. Criteria for Protein Identification {#sec4dot9-ijms-20-00314}
----------------------------------------

Identified peptides and proteins were validated using Scaffold (version Scaffold_4.8.6, Proteome Software Inc., Portland, OR, USA). With the help of Scaffold delta-mass correction, peptide identifications were accepted if they could be established at greater than 95.0% probability by the Peptide Prophet algorithm \[[@B49-ijms-20-00314]\]. For proteins, the probability had to be \>90% to achieve an FDR less than 1% and contained at least 2 identified peptides. Protein probabilities were assigned by the Protein Prophet algorithm \[[@B50-ijms-20-00314]\]. Proteins that contained similar peptides and could not be differentiated based on MS/MS analysis alone were grouped to satisfy the principles of parsimony.

4.10. Comparative Proteomics and Identification of Differentially Expressed Proteins {#sec4dot10-ijms-20-00314}
------------------------------------------------------------------------------------

The proteomic profile of all groups were analyzed. Coefficient of variation was used to measure intra assay variability (between the technical replicates) for group 1, 2, 3, and 4. Comparative analysis of the DEPs were performed between group 1 and group 3; and group 2 and group 4. Statistical significance of proteomic results was assessed by independent *t*-test. Different *p*-values were considered according to the abundance of the proteins: (i) Very Low abundance: spectral count range 1.7--7, *p* ≤ 0.001, and NSAF ratio ≥ 2.5 for overexpressed, ≤0.4 for underexpressed proteins; (ii) low abundance: spectral count range 8--19, *p* ≤ 0.01, and NSAF ratio ≥ 2.5 for overexpressed, ≤0.4 for underexpressed proteins; (iii) medium abundance: spectral count range between 20 and 79, *p* ≤ 0.05, and NSAF ratio ≥ 2.0 for overexpressed, ≤0.5 for underexpressed proteins; (iv) high abundance: spectral counts \> 80, *p* ≤ 0.05, and NSAF ratio ≥ 1.5 for overexpressed, ≤ 0.67 for underexpressed proteins.

4.11. Bioinformatic Analysis of DEPs {#sec4dot11-ijms-20-00314}
------------------------------------

Annotation of proteins was performed using Gene Ontology (GO) terms from National Center for Biotechnology Information (NCBI). Also, protein IDs and symbols were extracted from uniport database. DEPs identified in both study groups were subjected to functional annotation and enrichment analysis using publicly available bioinformatic annotation tools and databases, such as Universal Protein Resource (UniProt), Reactome and Database for Annotation Visualization and Integrated Discovery (DAVID) (<http://david.niaid.nih.gov>), and proprietary curated database Ingenuity pathway analysis (IPA) to analyze the involvement of DEPs in biological and cellular processes, pathways, regulatory networks, and protein-protein interactions.

Belinda Willard, Director of Proteomic Core Laboratory, Lerner Research Institute assisted with proteomic analysis. The Orbitrap Elite instrument was purchased via an NIH shared instrument grant, 1S10RR031537-01. Research support for this study was provided by the American Center for Reproductive Medicine.

Supplementary materials can be found at <http://www.mdpi.com/1422-0067/20/2/314/s1>.
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![Comparative proteomic analysis of semen samples with round cells and leukocytes ≥1 × 106/mL or round cells \< 1 × 10^6^/mL. (**a**) Total number of proteins detected in group 1 and group 3 run in triplicate (N1, N2, and N3), and differentially expressed proteins in group 1 vs. group 3; and (b) total number of proteins detected in group 2 and group 4 run in triplicate (N1, N2, and N3), and differentially expressed proteins in group 2 vs. group 4. Group 1 contained neat semen with round cells and leukocytes ≥ 1 × 10^6^/mL, group 2 contained neat semen with round cells ≥ 1 × 10^6^/mL that was processed by 65% density gradient to remove the round cells and leukocytes, group 3 contained neat semen with round cells \< 1 × 10^6^/mL, and group 4 contained neat semen with round cells \< 1 × 10^6^/mL that was processed by 65% density gradient to remove the round cells. CV: coefficient of variation, DEPs: differentially expressed proteins, OE: overexpressed, UE: underexpressed.](ijms-20-00314-g001){#ijms-20-00314-f001}

![Top networks associated with differentially expressed proteins in group 1 vs. group 3. (**a**) Cell death and survival, cellular compromise, cellular function, and maintenance; (**b**) cellular assembly and organization, cell signaling, molecular transport; and (**c**) cellular assembly and organization, embryonic development, organismal development. Group 1: neat semen samples with round cells and leukocytes ≥ 1 × 10^6^/mL. Group 3: neat semen samples with round cells \< 1 × 10^6^/mL.](ijms-20-00314-g002){#ijms-20-00314-f002}

![Schematic flowchart of overall experimental design. Normozoospermic samples were divided into four groups. Proteomic profile of sperm was evaluated by LC-MS/MS and compared with a pure leukocyte culture.](ijms-20-00314-g003){#ijms-20-00314-f003}

ijms-20-00314-t001_Table 1

###### 

Differentially expressed proteins and their abundance in semen samples from group 1 (≥1 × 10^6^/mL leukocytes) and group 3 (round cells \< 1 × 10^6^/mL).

  Uniprot No.   Gene Name   Protein Name                                                        Group 1   Group 3   NSAF Ratio   Expression           
  ------------- ----------- ------------------------------------------------------------------- --------- --------- ------------ ------------ ------- ----
  P15289        ARSA        Arylsulfatase A                                                     34.0      M         1.7          VL           0.05    UE
  P00352        ALDH1A1     Retinal dehydrogenase 1                                             26.3      M         2.7          VL           0.09    UE
  Q6PEW0        PRSS54      Inactive serine protease 54                                         18.0      L         4.7          VL           0.22    UE
  Q76KD6        SPATC1      Speriolin                                                           8.3       L         2.3          VL           0.26    UE
  Q9HAE3        EFCAB1      EF-hand calcium-binding domain-containing protein 1                 9.3       L         3.3          VL           0.33    UE
  O43707        ACTN4       Alpha-actinin-4                                                     44.7      M         23.3         L            0.47    UE
  P02788        LTF         Lactotransferrin                                                    2486.7    H         1299.0       H            0.47    UE
  P14314        PRKCSH      Glucosidase 2 subunit beta                                          123.0     H         65.0         M            0.48    UE
  P27797        CALR        Calreticulin                                                        271.7     H         175.0        H            0.57    UE
  P14625        HSP90B1     Endoplasmin                                                         987.0     H         660.3        H            0.60    UE
  P05023-4      ATP1A1      Isoform 4 of Sodium/potassium-transporting ATPase subunit alpha-1   98.7      H         181.3        H            1.61    OE
  O95202        LETM1       Mitochondrial proton/calcium exchanger protein                      29.0      M         65.7         M            2.04    OE
  O43242        PSMD3       26S proteasome non-ATPase regulatory subunit 3                      33.7      M         78.3         M            2.04    OE
  P23396        RPS3        40S ribosomal protein S3                                            24.7      M         60.0         M            2.20    OE
  P11234        RALB        Ras-related protein Ral-B                                           9.0       L         22.0         M            2.25    OE
  Q9NZM1-3      MYOF        Isoform 3 of Myoferlin                                              21.3      M         55.3         M            2.27    OE
  Q9Y4W6        AFG3L2      AFG3-like protein 2                                                 15.3      L         40.7         M            2.38    OE
  Q96RQ1        ERGIC2      Endoplasmic reticulum-Golgi intermediate compartment protein 2      8.3       L         23.0         M            2.52    OE
  Q8IYV9        IZUMO1      Izumo sperm-egg fusion protein 1                                    9.0       L         28.7         M            3.00    OE
  Q04609        FOLH1       Glutamate carboxypeptidase 2                                        27.0      M         96.3         H            3.21    OE
  Q8IY17-4      PNPLA6      Isoform 4 of Neuropathy target esterase                             3.7       VL        14.0         L            3.36    OE
  P62277        RPS13       40S ribosomal protein S13                                           5.3       VL        20.7         M            3.42    OE
  P46777        RPL5        60S ribosomal protein L5                                            5.7       VL        24.7         M            3.93    OE
  Q13093        PLA2G7      Platelet-activating factor acetylhydrolase                          5.3       VL        22.7         M            4.02    OE
  O43653        PSCA        Prostate stem cell antigen                                          1.7       VL        14.3         L            7.22    OE
  Q96M98-2      PACRG       Isoform 2 of Parkin coregulated gene protein                        1.3       VL        21.0         M            13.04   OE

VL: very low; L: low; M: medium; H: high; UE: underexpressed; OE: overexpressed; NSAF: normalized spectral abundance factor; Abun: abundance; SC: spectral count.

ijms-20-00314-t002_Table 2

###### 

Differentially expressed proteins and their abundance in processed semen samples from group 2 (≥1 × 10^6^/mL leukocytes) and group 4 (round cells \< 1 × 10^6^/mL).

  Uniprot No.   Gene Name   Protein Name                                      Group 2   Group 4   NSAF Ratio   Expression          
  ------------- ----------- ------------------------------------------------- --------- --------- ------------ ------------ ------ -------------------
  O75969        AKAP3       A-kinase anchor protein 3                         146.3     H         81.7         H            0.56   UE
  O96005        CLPTM1      Cleft lip and palate transmembrane protein 1      41.3      M         19.0         L            0.45   UE
  Q9Y619        SLC25A15    Mitochondrial ornithine transporter 1             26.0      M         12.0         L            0.47   UE
  Q8TF71        SLC16A10    Monocarboxylate transporter 10                    2.0       VL        0.0          \-           0.00   Unique to Group 2
  Q96ND0        FAM210A     Protein FAM210A                                   5.0       VL        0.7          VL           0.14   OE
  P12074        COX6A1      Cytochrome c oxidase subunit 6A1, mitochondrial   10.0      L         21.0         M            2.15   OE

VL: very low; L: low; M: medium; H: high; UE: underexpressed; OE: overexpressed; NSAF: normalized spectral abundance factor; Abun: abundance; SC: spectral count.

ijms-20-00314-t003_Table 3

###### 

Differentially expressed proteins and their abundance in semen samples from group 1 (≥1 × 10^6^/mL leukocytes), group 3 (round cells \< 1 × 10^6^/mL), and control group (pure leukocyte culture).

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Uniprot No.   Gene Name   Protein Name                                                        Group 1   Group 3   Control Group (CG)   NSAF Ratio\   Expression\                
                                                                                                                                         CG/ Group1    in CG                      
  ------------- ----------- ------------------------------------------------------------------- --------- --------- -------------------- ------------- ------------- ---- ------- --------------
  P00352        ALDH1A1     Retinal dehydrogenase 1                                             26.3      M         2.7                  VL            0.0           \-   0.00    Absent in CG

  Q6PEW0        PRSS54      Inactive serine protease 54                                         18.0      L         4.7                  VL            0.0           \-   0.00    Absent in CG

  Q76KD6        SPATC1      Speriolin                                                           8.3       L         2.3                  VL            0.0           \-   0.00    Absent in CG

  Q9HAE3        EFCAB1      EF-hand calcium-binding domain-containing protein 1                 9.3       L         3.3                  VL            0.0           \-   0.00    Absent in CG

  O43242        PSMD3       26S proteasome non-ATPase regulatory subunit 3                      33.7      M         78.3                 M             0.0           \-   0.00    Absent in CG

  P23396        RPS3        40S ribosomal protein S3                                            24.7      M         60.0                 M             0.0           \-   0.00    Absent in CG

  Q9NZM1-3      MYOF        Isoform 3 of Myoferlin                                              21.3      M         55.3                 M             0.0           \-   0.00    Absent in CG

  Q96RQ1        ERGIC2      Endoplasmic reticulum-Golgi intermediate compartment protein 2      8.3       L         23.0                 M             0.0           \-   0.00    Absent in CG

  Q8IYV9        IZUMO1      Izumo sperm-egg fusion protein 1                                    9.0       L         28.7                 M             0.0           \-   0.00    Absent in CG

  Q04609        FOLH1       Glutamate carboxypeptidase 2                                        27.0      M         96.3                 H             0.0           \-   0.00    Absent in CG

  Q8IY17-4      PNPLA6      Isoform 4 of Neuropathy target esterase                             3.7       VL        14.0                 L             0.0           \-   0.00    Absent in CG

  P62277        RPS13       40S ribosomal protein S13                                           5.3       VL        20.7                 M             0.0           \-   0.00    Absent in CG

  Q13093        PLA2G7      Platelet-activating factor acetylhydrolase                          5.3       VL        22.7                 M             0.0           \-   0.00    Absent in CG

  O43653        PSCA        Prostate stem cell antigen                                          1.7       VL        14.3                 L             0.0           \-   0.00    Absent in CG

  Q96M98-2      PACRG       Isoform 2 of Parkin coregulated gene protein                        1.3       VL        21.0                 M             0.0           \-   0.00    Absent in CG

  P46777        RPL5        60S ribosomal protein L5                                            5.7       VL        24.7                 M             1.3           M    0.36    UE

  P15289        ARSA        Arylsulfatase A                                                     34.0      M         1.7                  VL            4.7           VL   0.20    UE

  P02788        LTF         Lactotransferrin                                                    2486.7    H         1299.0               H             424.3         H    0.24    UE

  P14314        PRKCSH      Glucosidase 2 subunit beta                                          123.0     H         65.0                 M             33.7          M    0.39    UE

  P27797        CALR        Calreticulin                                                        271.7     H         175.0                H             123.0         H    0.65    UE

  P14625        HSP90B1     Endoplasmin                                                         987.0     H         660.3                H             73.3          M    0.11    UE

  P05023-4      ATP1A1      Isoform 4 of Sodium/potassium-transporting ATPase subunit alpha-1   98.7      H         181.3                H             27.3          M    0.39    UE

  O95202        LETM1       Mitochondrial proton/calcium exchanger protein                      29.0      M         65.7                 M             9.0           L    0.46    UE

  Q9Y4W6        AFG3L2      AFG3-like protein 2                                                 15.3      L         40.7                 M             0.7           VL   0.06    UE

  P11234        RALB        Ras-related protein Ral-B                                           9.0       L         22.0                 M             62.0          M    10.12   OE

  O43707        ACTN4       Alpha-actinin-4                                                     44.7      M         23.3                 L             52.3          M    1.73    OE
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Expression VL: very low; L: low; M: medium; H: high; UE: underexpressed; OE: overexpressed; NSAF: normalized spectral abundance factor; Abun: abundance; SC: spectral count; CG: control group.
